secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0001178913-23-003962
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio raises ~$6.6M in registered direct offering; issues shares and warrants
--------------------------------------------------------------------------------

- Aggregate proceeds ~$6.6M from sale of 7,916,879 units at $0.835 each.
- Each unit includes one ordinary share (or pre-funded warrant) and one five-year warrant to purchase an ordinary share at $1.00.
- Warrants exercisable immediately; if all for cash, additional ~$7.9M potential proceeds.
- CEO Miranda Toledano and Chairman Gerald Lieberman participated in the placement.
- Company to file resale registration statement within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891323003962/0001178913-23-003962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891323003962/zk2330685.htm
  HTML page:      https://secwatch.observer/filing/0001178913-23-003962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer